Rhinomed Limited (ASX:$RNO) has requested a trading halt from ASX in relation to an application to be removed from the official list of ASX. The trading halt will be in place until the company makes the announcement or the commencement of trading on Monday, 11 December 2023.
Rhinomed Limited has requested a trading halt from ASX as it prepares to make an announcement regarding its application to be removed from the official list of ASX. The company wishes for the trading halt to remain until the announcement is made or the commencement of trading on Monday, 11 December 2023. Rhinomed's Company Secretary, Sean Slattery, has confirmed the request for the trading halt in accordance with ASX Listing Rule 17.1.
Rhinomed Limited (ASX:RNO) has sought a trading halt from ASX as it prepares to release an announcement regarding its application to be removed from the official list of ASX. The company aims to keep the trading halt in place until the announcement is made or the commencement of trading on Monday, 11 December 2023. Rhinomed, a Melbourne-based nasal and airway technology company, has developed an innovative nasal technology platform that enhances air flow and offers drug delivery and diagnostic capabilities. The market awaits the forthcoming announcement to gain insights into Rhinomed's strategic decision and future plans.